Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials Post author:Sam Post published:March 4, 2018 Post category:BioPharma Dermira plans to shutter the program and move on to more promising compounds. Source: BioSpace You Might Also Like InfuSystem Holdings, Inc. To Issue Fourth Quarter And Year End 2016 Financial Results On Wednesday, March 22, 2017 March 16, 2017 Zynerba Release: Company Announces Proposed Public Offering Of Common Stock January 18, 2017 How Gilead and Kite Pharma's Flirtation Became the Real Thing September 5, 2017
InfuSystem Holdings, Inc. To Issue Fourth Quarter And Year End 2016 Financial Results On Wednesday, March 22, 2017 March 16, 2017
